CLEVELAND, Ohio – Actor and playwright Molly McFadden – whose life has been touched by Alzheimer’s disease – will present her one-woman play about the illness and participate in a post ...

The team focused on Aβ42, a form of the amyloid beta with 42 amino acids that is commonly found in people with Alzheimer's disease. The researchers used three techniques in their work.

Future research will, hopefully, at least help experts understand how antiviral treatment affects Alzheimer’s risk, as well as identify better ways to detect when HSV-1 is active in the brain.

Two jobs are linked to a lower Alzheimer's risk. Even if you do a different kind of work or are retired, these jobs show how to keep your mind sharp.

Researchers at the University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease that could help protect the brain from damage and preserve cognitive ...

ATLANTA — New data shows that there are more people living with Alzheimer’s Disease than ever before. Channel 2’s Linda Stouffer spoke with a doctor about the urgent effort to get people to ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find ...

Researchers engaged 20 individuals diagnosed with Alzheimer’s and gave them 20 grams of creatine per day for eight weeks. 20 grams is on the high side in my experience but well within the bounds ...

By WDIO Updated: May 29, 2025 - 6:35 PM Published: May 29, 2025 - 10:49 AM ...

Phil Robertson, star of "Duck Dynasty," has died at the age of 79, his family announced. Robertson had previously been diagnosed with Alzheimer's disease and a blood disorder.

Herpes simplex virus 1 (HSV-1) infection is associated with an increased risk of developing Alzheimer’s disease (AD), but treating the viral infection may offer protection, a new study found. In ...

Sanofi acquisition adds Alzheimer’s drug to pipeline From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 million, adding an ...